PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether gonadotropin releasing hormone agonists
(medical therapy) will protect against ovarian failure in reproductive aged women undergoing
sterilizing chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborators:
Canadian Institutes of Health Research (CIHR) Queen's University University of Ottawa